Market cap
₹29 Cr
Revenue (TTM)
₹11 Cr
P/E Ratio
5.6
P/B Ratio
1.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 112.56 | -41.96 | -28.32 |
| EBIT | -2.38 | 62.77 | 322.85 | 74.82 | -197.99 |
| Net Profit | -106.59 | -124.07 | 414.69 | 104.88 | 56.81 |
| EPS | -106.53 | -123.73 | 414.39 | 64.37 | 38.96 |
| Book Value | -- | -- | -2.40 | -1.10 | 2.98 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-25 | Mar-24 |
| EBIT-Margin
| -26.00 | -13.74 | 18.08 | -21.13 | -55.99 |
| Net Margin
| -12.39 | -6.82 | 37.58 | 12.83 | -51.49 |
| Return on equity
| -10.12 | -2.57 | 26.43 | 4.76 | -41.80 |
| Return on Capital
| -6.76 | 0.62 | -- | 1.75 | -29.74 |
| Return on Assets
| -3.56 | -0.69 | 12.32 | 1.82 | -14.93 |
| Debt to Equity (x)
| -- | -- | 0.08 | 0.61 | 0.61 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
ROE
26.43
Higher than Peers by 18.01
Profit after tax / Average Net worth * 100
ROA
12.32
Higher than Peers by 7.04
Profit after tax / Average Total assets * 100
EBIT Margin
18.08
Higher than Peers by 10.41
Operating profit (EBIT) / Net Sales * 100
Net Margin
37.58
Higher than Peers by 32.05
Net profit / Total Income (Net sales plus other income) * 100
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
Revenue Growth
112.56
Higher than Peers by 106.44
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Vaxtex Cotfab
|
112.56
|
-68.39
|
-78.02
|
22.15
|
136.71
|
-5.78
|
|||||
|
Peer Median
|
6.13
|
11.13
|
2.51
|
30.21
|
35.15
|
-15.99
|
EBIT Growth
322.85
Higher than Peers by 311.74
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Vaxtex Cotfab
|
322.85
|
88.07
|
-1,317.96
|
-124.20
|
110.85
|
4.71
|
|||||
|
Peer Median
|
11.11
|
51.57
|
10.23
|
11.71
|
168.40
|
-38.03
|
Net Profit Growth
414.69
Higher than Peers by 400.01
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Vaxtex Cotfab
|
414.69
|
110.00
|
-880.40
|
-23.82
|
733.32
|
91.31
|
|||||
|
Peer Median
|
14.68
|
41.23
|
18.43
|
-10.32
|
122.73
|
-25.14
|
EPS Growth
414.39
Higher than Peers by 400.25
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Vaxtex Cotfab
|
414.39
|
110.00
|
-636.61
|
-39.46
|
731.46
|
91.72
|
|||||
|
Peer Median
|
14.14
|
39.84
|
--
|
-4.15
|
113.16
|
-22.57
|
Book Value Growth
--
--
Year on year growth in book value per share
Solvency
Debt to Equity
0.08
Higher than Peers by 0.05
Total debt / Net worth
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
Current Ratio
2.84
Higher than Peers by 0.57
Current Assets / Current Liabilities and Provisions
Quick Ratio
2.27
Higher than Peers by 0.93
(Current Assets - Inventory) / Current Liabilities and Provisions
Interest Coverage
76.78
Higher than Peers by 70.76
Earning before interest and taxes (EBIT) / Interest Expenses
Operating Efficiency
Debtors to sales
63.54
Higher than Peers by 47.02
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Vaxtex Cotfab
|
63.54
|
266.09
|
94.54
|
24.09
|
10.01
|
37.42
|
|||||
|
Peer Median
|
16.52
|
20.74
|
18.50
|
18.73
|
16.30
|
30.83
|
Asset Turnover
0.26
Lower than Peers by 0.71
Sales / Average Total Assets
Receivable days
--
--
Average Debtors / Sales * 365
Inventory Days
--
--
Average Inventory / Sales * 365
Payable days
--
--
Average Creditors / Cost of goods sold * 365
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
Valuation
Price / Earnings
5.56
Lower than Peers by 11.20
Current share price divided by earning per share in the last twelve months
Price / Book Value
1.31
Lower than Peers by 0.52
Current share price divided by book value per share in the latest financial year
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
EV/EBITDA
6.85
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
Market Cap
29
Lower than Peers by 1,205
Current Share price multiplied by latest total number of shares outstanding